SWOT Analysis for NLS Pharmaceutics Ltd

Significant (over 30%) distance from 52 week high
Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Highest Recovery from 52 Week Low

Stocks with Quarter Change % less than Industry
Highest fall from 52 Week High
Top Losers
Low Piotroski Score : Companies with weak financials
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

NLS Pharmaceutics Ltd SWOT Analysis: Strengths, Weakness, Opportunity, and Threats